ArticleScientific reports2026
Embigin is involved in the regulation of early mouse kidney development.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Embigin (Gp70) is a transmembrane glycoprotein that serves as an ancillary protein for monocarboxylate transporters and functions as a fibronectin receptor. In mice, embigin is associated with the regulation of stem and progenitor cells as well as embryonic development. Our study demonstrates that embigin has a prominent role in early mouse kidney development. We found that during early kidney morphogenesis, embigin protein is present in the ureteric bud (UB) and differentiating nephron precursors. Notably, the absence of embigin retards UB branching. In the E13.5 Emb−/− kidneys, we observed a downregulation of genes linked to nephron development, including those involved in podocyte development. However, by E17.5, we found no significant transcriptional or morphological differences, suggesting a transient delay in the Emb−/− kidneys. Furthermore, reanalysis of mouse embryonic single-cell RNA sequencing data revealed that embigin is expressed in renal primordial cells as early as E8.75. Additionally, in embigin knockdown mouse epithelial cells, we noted a downregulation of genes central to kidney development and function, including Pappa2, Acta2, and Tagln, which are also downregulated in the E13.5 Emb−/− kidneys. Overall, our findings indicate that embigin plays a significant role in mouse early development by supporting the functions of tissue-specific stem cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.